EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparative dosimetric study of h-IMRT and VMAT plans for breast cancer after breast-conserving surgery

Min Zhang, Fang-Xu Zhang, Xiao-Lei Yang, Qian Liang, Jian Liu, Wei-Bing Zhou

Translational Oncology · 2024-09 · 47 · 102012

DOI: 10.1016/j.tranon.2024.102012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2024-09. Verfasst von Min Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya Hospital, Central South University, Hunan 41000, PR China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: To compare the dosimetric advantages and disadvantages between hybrid intensity-modulated radiation therapy (h-IMRT) and the volumetric modulated arc therapy (VMAT) technique in hypofractionated whole-breast irradiation (HF-WBI) for early-stage breast cancer (BC). METHODS: The dose distribution of h-IMRT and VMAT plans was compared in 20 breast cancer patients. This comparison included evaluation of dosimetric parameters using dose volume histograms (DVHs) for the planning target volume (PTV) and organs-at-risk (OARs). Additionally, the study examined the normal tissue complication probability (NTCP), the second cancer complication probability (SCCP) and the tumor control probability (TCP) based on different models. RESULTS: Significant differences were detected between the two plans, in terms of Machine units (MUs), the control points, 95 % volume (V95 %), dose homogeneity index (DHI) and conformity index (CI). The endpoint of grade II radiation pneumonitis and cardiac death due to ischemic heart disease were assessed. In h-IMRT plan, the NTCP values were marginally lower for radiation pneumonitis and slightly higher for cardiac death compared to VMAT plan, as determined by the Lyman-Kutcher-Burman model. The Schneider model was employed to predict the SCCP for both the bilateral lungs and contralateral breast, the results demonstrate that the h-IMRT plan outperforms the VMAT plan, with statistical significance. Additionally, the LQ-Poisson model was employed to forecast the TCP of the PTV, showing that the h-IMRT plan outperformed the VMAT plan (P > 0.05). CONCLUSION: The h-IMRT technique, offering superior dose coverage and better therapeutic efficacy with fewer side effects as calculated by models, is more suitable for HF-WBI compared to the VMAT technique.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerIMRTNTCPSCCPTCPVMAT

Autor:innen und Institutionen

  • Xiangya Hospital, Central South University, Hunan 41000, PR China.
  • Fourth People's Hospital of Jinan, Jinan 250031, PR China.
  • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Otolaryngology-Head and Neck Surgery, QingPu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, PR China.
  • Xiangya Hospital, Central South University, Hunan 41000, PR China. Electronic address: zhouweibing298@163.com.

Zitieren

APA

Zhang, M., Zhang, F. X., Yang, X. L., Liang, Q., Liu, J., & Zhou, W. B. (2024). Comparative dosimetric study of h-IMRT and VMAT plans for breast cancer after breast-conserving surgery. Translational Oncology, 47, 102012. https://doi.org/10.1016/j.tranon.2024.102012

Vancouver

Zhang M, Zhang FX, Yang XL, Liang Q, Liu J, Zhou WB. Comparative dosimetric study of h-IMRT and VMAT plans for breast cancer after breast-conserving surgery. Translational Oncology. 2024;47:102012. doi:10.1016/j.tranon.2024.102012

BibTeX
@article{Zhang2024,
  author = {Zhang, Min and Zhang, Fang-Xu and Yang, Xiao-Lei and Liang, Qian and Liu, Jian and Zhou, Wei-Bing},
  title = {Comparative dosimetric study of h-IMRT and VMAT plans for breast cancer after breast-conserving surgery},
  journal = {Translational Oncology},
  year = {2024},
  volume = {47},
  pages = {102012},
  doi = {10.1016/j.tranon.2024.102012}
}
Kostenlos starten →